Psychiatr. praxi. 2014;15(3):108-111

Dual-action antidepressants - the use in clinical practice

doc.MUDr.Martin Bareš, Ph.D.
Psychiatrické centrum Praha

Dual-action antidepressants (duloxetine, mirtazapine, venlafaxine) are widely used in clinical practice. The author comments and compare

their mutual efficacy in the treatment of major depression, tolerability, use in other indications and in the treatment of special

populations (depression in old age, pregnancy, breast-feeding).

Keywords: duloxetine, mirtazapine, venlafaxine, milnacipram, dual-action antidepressants

Published: November 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bareš M. Dual-action antidepressants - the use in clinical practice. Psychiatr. praxi. 2014;15(3):108-111.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 200 9; 373(9665): 746-758.
    2. Montgomery SA, Baldwin DS, Blier P, et al. Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol 2007; 22(6): 323-32 9. Go to original source... Go to PubMed...
    3. Papakostas GI, Thase ME, Fava M, et al. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol Psychiatry 2007; 62(11): 1217-1227. Go to original source... Go to PubMed...
    4. Látalova K, Pidrman V. Antidepresiva s duálním působením - účinnost a indikace. Klin Farmakol Farm 2004; 18: 218-222.
    5. Raboch J. Použití novějších antidepresiv v klinické praxi. Farmakoterapie 2005(6): 595-602.
    6. Watanabe N, Omori IM, Nakagawa A, et al. Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. J Clin Psychiatry 2008; 6 9(9): 1404-1415. Go to original source... Go to PubMed...
    7. Baldomero EB, Ubago JG, Cercos CL, et al. Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study. Depress Anxiety 2005; 22(2): 68-76. Go to original source... Go to PubMed...
    8. Fang Y, Yuan C, Xu Y, et al. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population. J Clin Psychopharmacol 2010; 30(4): 357-364. Go to original source... Go to PubMed...
    9. Schueler YB, Koesters M, Wieseler B, et al. A systematic review of duloxetine and venlafaxine in major depression, including unpublished data. Acta Psychiatr Scand 2011; 123(4): 247-265. Go to original source... Go to PubMed...
    10. Hu XH, Bull SA, Hunkeler EM, et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 2004; 65(7): 959-965. Go to original source... Go to PubMed...
    11. Bauer M, Pfennig A, Severus E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry 2013; 14(5): 334-385. Go to original source... Go to PubMed...
    12. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010; 71(10): 1259-1272. Go to original source... Go to PubMed...
    13. Bazire S. Psychotropic Drug Directory 2012. The professional´s pocket handbook and aide memoire. Dorsington: Lloyd-Rheinhold Communications 2012: 540s.
    14. Mulsant BH, Pollock BG. Psychopharmacology. In: Clinical manual of geriatric psychiatry. Thakur ME, Glazer DG, Steffens DC (eds). Arlington: American Psychiatric Publishing; 2013. pp. 17-83. Go to original source...
    15. Schatzberg AF, Nemeroff CB. Essentials of clinical psychopharmacology. Arlington: American Psychiatric Publishing 2013: 877s.
    16. Muehlbacher M, Nickel MK, Nickel C, et al. Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2005; 25(6): 580-583. Go to original source... Go to PubMed...
    17. Berk M, Ichim C, Brook S. Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Int Clin Psychopharmacol 2001; 16(2): 87-92. Go to original source... Go to PubMed...
    18. Davidson J, Baldwin D, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry 2006; 63(10): 1158-1165. Go to original source... Go to PubMed...
    19. Davidson J, Rothbaum BO, Tucker P, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol 2006; 26(3): 259-267. Go to original source... Go to PubMed...
    20. Freeman EW, Rickels K, Yonkers KA, et al. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol 2001; 98(5 Pt 1): 737-744. Go to original source... Go to PubMed...
    21. Sie SD, Wennink JM, van Driel JJ, et al. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation. Arch Dis Child Fetal Neonatal Ed 2012; 97(6): F472-F476. Go to original source... Go to PubMed...
    22. Byatt N, Deligiannidis KM, Freeman MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand 2013; 127(2): 94-114. Go to original source... Go to PubMed...
    23. Patil AS, Kuller JA, Rhee EH. Antidepressants in pregnancy: a review of commonly prescribed medications. Obstet Gynecol Surv 2011; 66(12): 777-787. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.